Urologix Inc - ULGX - Financial Statement Analysis
All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.
In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.
Financial statement analysis updated: May 26, 2013
Urologix Inc - SIC # 3845
| Ticker | Exchange | SIC # | Website | Latest Ticker |
|---|---|---|---|---|
| ULGX | Nasdaq | 3845 | http://www.urologix.com/ |
0.50  +0.01
|
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: |
||||
Latest Headlines for Urologix Inc
UROLOGIX INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Tran - May 23rd, 2013 7:10 am
UROLOGIX INC Financials - May 21st, 2013 11:04 am
UROLOGIX INC Files SEC form 10-Q, Quarterly Report - May 14th, 2013 6:33 am
UROLOGIX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits - May 2nd, 2013 4:50 am
Urologix's CEO Discusses F3Q 2013 Results - Earnings Call Transcript - May 1st, 2013 8:50 pm
View All Current Headlines >> |
||||
